• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估噬菌体展示发现的肽作为前列腺特异性膜抗原 (PSMA) 的配体。

Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).

机构信息

Radiology, Washington University, St Louis, Missouri, United States of America.

出版信息

PLoS One. 2013 Jul 25;8(7):e68339. doi: 10.1371/journal.pone.0068339. Print 2013.

DOI:10.1371/journal.pone.0068339
PMID:23935860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3723849/
Abstract

The aim of this study was to identify potential ligands of PSMA suitable for further development as novel PSMA-targeted peptides using phage display technology. The human PSMA protein was immobilized as a target followed by incubation with a 15-mer phage display random peptide library. After one round of prescreening and two rounds of screening, high-stringency screening at the third round of panning was performed to identify the highest affinity binders. Phages which had a specific binding activity to PSMA in human prostate cancer cells were isolated and the DNA corresponding to the 15-mers were sequenced to provide three consensus sequences: GDHSPFT, SHFSVGS and EVPRLSLLAVFL as well as other sequences that did not display consensus. Two of the peptide sequences deduced from DNA sequencing of binding phages, SHSFSVGSGDHSPFT and GRFLTGGTGRLLRIS were labeled with 5-carboxyfluorescein and shown to bind and co-internalize with PSMA on human prostate cancer cells by fluorescence microscopy. The high stringency requirements yielded peptides with affinities KD~1 µM or greater which are suitable starting points for affinity maturation. While these values were less than anticipated, the high stringency did yield peptide sequences that apparently bound to different surfaces on PSMA. These peptide sequences could be the basis for further development of peptides for prostate cancer tumor imaging and therapy.

摘要

本研究旨在鉴定适用于进一步开发的 PSMA 潜在配体,这些配体可作为新型 PSMA 靶向肽,使用噬菌体展示技术。将人 PSMA 蛋白固定为靶标,然后与 15 肽噬菌体展示随机肽库孵育。经过一轮预筛选和两轮筛选,在第三轮淘选中进行高严格性筛选,以鉴定最高亲和力结合物。分离出与人前列腺癌细胞中 PSMA 具有特异性结合活性的噬菌体,并对相应的 15 肽 DNA 进行测序,提供三个共有序列:GDHSPFT、SHFSVGS 和 EVPRLSLLAVFL 以及其他未显示共有序列的序列。从结合噬菌体的 DNA 测序推导的两个肽序列,SHFSVGSGDHSPFT 和 GRFLTGGTGRLLRIS 用 5-羧基荧光素标记,并通过荧光显微镜显示与人前列腺癌细胞上的 PSMA 结合和共内化。高严格性要求产生了亲和力 KD~1 µM 或更高的肽,这些肽是亲和力成熟的合适起点。虽然这些值低于预期,但高严格性确实产生了显然与 PSMA 不同表面结合的肽序列。这些肽序列可能是进一步开发用于前列腺癌肿瘤成像和治疗的肽的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/85a1e4460261/pone.0068339.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/148b1839f80f/pone.0068339.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/8dc42778e774/pone.0068339.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/15117324a732/pone.0068339.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/738297410c8e/pone.0068339.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/6f6dc4f6f9b8/pone.0068339.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/85a1e4460261/pone.0068339.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/148b1839f80f/pone.0068339.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/8dc42778e774/pone.0068339.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/15117324a732/pone.0068339.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/738297410c8e/pone.0068339.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/6f6dc4f6f9b8/pone.0068339.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ad/3723849/85a1e4460261/pone.0068339.g006.jpg

相似文献

1
Evaluation of phage display discovered peptides as ligands for prostate-specific membrane antigen (PSMA).评估噬菌体展示发现的肽作为前列腺特异性膜抗原 (PSMA) 的配体。
PLoS One. 2013 Jul 25;8(7):e68339. doi: 10.1371/journal.pone.0068339. Print 2013.
2
Selection of Single Chain Antibody Fragments for Targeting Prostate Specific Membrane Antigen: A Comparison Between Cell-based and Antigen-based Approach.用于靶向前列腺特异性膜抗原的单链抗体片段的筛选:基于细胞和基于抗原方法的比较
Protein Pept Lett. 2016;23(4):336-42. doi: 10.2174/0929866523666160115131403.
3
Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.与前列腺特异性膜抗原细胞外部分结合的二硫键约束肽。
Mol Cancer Ther. 2004 May;3(5):597-603.
4
Discovery of PSMA-specific peptide ligands for targeted drug delivery.用于靶向药物递送的PSMA特异性肽配体的发现。
Int J Pharm. 2016 Nov 20;513(1-2):138-147. doi: 10.1016/j.ijpharm.2016.08.048. Epub 2016 Aug 28.
5
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity.一种二聚体肽,它能选择性地结合前列腺特异性膜抗原并抑制其酶活性。
Cancer Res. 2006 Sep 15;66(18):9171-7. doi: 10.1158/0008-5472.CAN-06-1520.
6
Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer.前列腺特异性抗原、其分子形式及其他用于检测前列腺癌的激肽释放酶标志物。
Urology. 2002 Jan;59(1):2-8. doi: 10.1016/s0090-4295(01)01449-2.
7
Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.从噬菌体展示肽文库中筛选与 VPAC1 受体特异性结合的肽。
PLoS One. 2013;8(1):e54264. doi: 10.1371/journal.pone.0054264. Epub 2013 Jan 24.
8
Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device.使用微芯片装置对前列腺癌细胞和蛋白质生物标志物进行分离与双重检测。
Lab Chip. 2017 Jan 31;17(3):415-428. doi: 10.1039/c6lc01279e.
9
Construction of a chimeric antigen receptor bearing a nanobody against prostate a specific membrane antigen in prostate cancer.构建一种嵌合抗原受体,该受体携带针对前列腺特异性膜抗原的纳米抗体用于前列腺癌。
J Cell Biochem. 2019 Jun;120(6):10787-10795. doi: 10.1002/jcb.28370. Epub 2019 Jan 22.
10
Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements.Ad5/35E1aPSESE4:一种利用由前列腺特异性抗原(PSA)/前列腺特异性膜抗原(PSMA)转录调控元件控制的具有复制能力的腺病毒标记循环前列腺肿瘤细胞的新方法。
Cancer Lett. 2016 Mar 1;372(1):57-64. doi: 10.1016/j.canlet.2015.12.018. Epub 2015 Dec 23.

引用本文的文献

1
Prodrugs Targeting Prostate-Specific Membrane Antigen against Prostate Cancer.靶向前列腺特异性膜抗原的前药用于治疗前列腺癌
J Med Chem. 2025 Jun 26;68(12):12296-12330. doi: 10.1021/acs.jmedchem.4c02626. Epub 2025 Jun 12.
2
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.癌症成像与荧光引导手术中的双标记小肽:进展与未来展望
Pharmaceuticals (Basel). 2025 Jan 22;18(2):143. doi: 10.3390/ph18020143.
3
PEtOx-DOPE nanoliposomes functionalized with peptide 563 in targeted delivery to prostate cancer.

本文引用的文献

1
Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.用于前列腺癌筛查的前列腺特异性抗原检测:美国临床肿瘤学会临时临床意见
J Oncol Pract. 2012 Sep;8(5):315-7. doi: 10.1200/JOP.2012.000715.
2
Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion.用前列腺特异性抗原检测进行前列腺癌筛查:美国临床肿瘤学会临时临床意见。
J Clin Oncol. 2012 Aug 20;30(24):3020-5. doi: 10.1200/JCO.2012.43.3441. Epub 2012 Jul 16.
3
Virus-polymer hybrid nanowires tailored to detect prostate-specific membrane antigen.
用肽563功能化的PEtOx-DOPE纳米脂质体在前列腺癌的靶向递送中应用。
Turk J Biol. 2024 May 23;48(3):174-181. doi: 10.55730/1300-0152.2693. eCollection 2024.
4
Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases.噬菌体疗法对抗感染性疾病的现状及超越感染性疾病的潜在应用。
Int J Clin Pract. 2022 Oct 3;2022:4913146. doi: 10.1155/2022/4913146. eCollection 2022.
5
Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine.通过携带共刺激TNFSF配体和GM-CSF细胞因子的PSMA靶向免疫调节病毒样颗粒增强抗肿瘤反应。
Mol Ther Oncolytics. 2022 Feb 17;24:650-662. doi: 10.1016/j.omto.2022.02.010. eCollection 2022 Mar 17.
6
PSMA-positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state.前列腺癌细胞分泌的 PSMA 阳性膜具有将血管内皮细胞转化为血管生成状态的能力。
Prostate. 2021 Dec;81(16):1390-1401. doi: 10.1002/pros.24237. Epub 2021 Sep 13.
7
Evolving Castration Resistance and Prostate Specific Membrane Antigen Expression: Implications for Patient Management.不断演变的去势抵抗和前列腺特异性膜抗原表达:对患者管理的影响
Cancers (Basel). 2021 Jul 16;13(14):3556. doi: 10.3390/cancers13143556.
8
Nanobodies Targeting Prostate-Specific Membrane Antigen for the Imaging and Therapy of Prostate Cancer.靶向前列腺特异性膜抗原的纳米抗体用于前列腺癌的成像和治疗。
J Med Chem. 2020 Jul 23;63(14):7601-7615. doi: 10.1021/acs.jmedchem.0c00418. Epub 2020 Jun 8.
9
Size Matters: Arginine-Derived Peptides Targeting the PSMA Receptor Can Efficiently Complex but Not Transfect siRNA.尺寸很重要:靶向前列腺特异性膜抗原(PSMA)受体的精氨酸衍生肽能有效结合但不能转染小干扰RNA(siRNA)。
Mol Ther Nucleic Acids. 2019 Dec 6;18:863-870. doi: 10.1016/j.omtn.2019.10.013. Epub 2019 Oct 23.
10
Targeted nonviral gene therapy in prostate cancer.前列腺癌的靶向非病毒基因治疗。
Int J Nanomedicine. 2018 Sep 25;13:5753-5767. doi: 10.2147/IJN.S139080. eCollection 2018.
病毒-聚合物杂化纳米线,经精心设计可用于检测前列腺特异性膜抗原。
Anal Chem. 2012 Mar 20;84(6):2776-83. doi: 10.1021/ac203143y. Epub 2012 Mar 7.
4
Bio-inspired design and potential biomedical applications of a novel class of high-affinity peptides.
Angew Chem Int Ed Engl. 2012 Feb 20;51(8):1890-4. doi: 10.1002/anie.201107894. Epub 2012 Jan 24.
5
A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).一种制备前列腺特异性膜抗原(PSMA)多价抑制剂的模块化策略。
Oncotarget. 2011 Dec;2(12):1244-53. doi: 10.18632/oncotarget.415.
6
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.2-(3-{1-羧基-5-[(6-[18F]氟吡啶-3-羰基)-氨基]-戊基}-脲基)-戊二酸,[18F]DCFPyL,一种用于前列腺癌的 PSMA 基 PET 成像剂。
Clin Cancer Res. 2011 Dec 15;17(24):7645-53. doi: 10.1158/1078-0432.CCR-11-1357. Epub 2011 Oct 31.
7
Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.使用前列腺特异性膜抗原双模态抑制剂对前列腺癌实验模型进行序贯单光子发射计算机断层扫描和光学成像
Angew Chem Int Ed Engl. 2011 Sep 19;50(39):9167-70. doi: 10.1002/anie.201102872. Epub 2011 Aug 22.
8
Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using AlphaScreen technology.开发一种适用于使用AlphaScreen技术进行高通量筛选的新型非放射性核酸与TDP-43结合检测方法。
J Biomol Screen. 2010 Oct;15(9):1099-106. doi: 10.1177/1087057110382778. Epub 2010 Sep 20.
9
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.高水平的 PSMA 表达与手术治疗的前列腺癌中早期 PSA 复发相关。
Prostate. 2011 Feb 15;71(3):281-8. doi: 10.1002/pros.21241. Epub 2010 Aug 31.
10
68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.68Ga 标记的前列腺特异性膜抗原(PSMA)抑制剂用于前列腺癌成像。
J Med Chem. 2010 Jul 22;53(14):5333-41. doi: 10.1021/jm100623e.